Cargando…
The Feasibility of Patient-Specific Circulating Tumor DNA Monitoring throughout Multi-Modality Therapy for Locally Advanced Esophageal and Rectal Cancer: A Potential Biomarker for Early Detection of Subclinical Disease
As non-operative management (NOM) of esophageal and rectal cancer is becoming more prevalent, blood-biomarkers such as circulating tumor DNA (ctDNA) may provide clinical information in addition to endoscopy and imaging to aid in treatment decisions following chemotherapy and radiation therapy. In th...
Autores principales: | Boniface, Christopher, Deig, Christopher, Halsey, Carol, Kelley, Taylor, Heskett, Michael B., Thomas, Charles R., Spellman, Paul T., Nabavizadeh, Nima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824834/ https://www.ncbi.nlm.nih.gov/pubmed/33466369 http://dx.doi.org/10.3390/diagnostics11010073 |
Ejemplares similares
-
Circulating tumor DNA dynamics using patient-customized assays are associated with outcome in neoadjuvantly treated breast cancer
por: Butler, Timothy M., et al.
Publicado: (2019) -
Blood, Toil, and Taxoteres: Biological Determinants of Treatment-Induced ctDNA Dynamics for Interpreting Tumor Response
por: Boniface, Christopher T., et al.
Publicado: (2022) -
Corrigendum: Blood, toil, and taxoteres: Biological determinants of treatment-induced ctDNA dynamics for interpreting tumor response
por: Boniface, Christopher T., et al.
Publicado: (2023) -
Differential Allelic Expression among Long Non-Coding RNAs
por: Heskett, Michael B., et al.
Publicado: (2021) -
Epigenetic control of chromosome-associated lncRNA genes essential for replication and stability
por: Heskett, Michael B., et al.
Publicado: (2022)